NY A 11256
in committeeRequires health plan coverage to include certain generic drugs and biosimilars
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 11256 pass?
Not yet. NY A 11256 is in committee as of 2026-05-04 and has not come to a final vote. Latest recorded action (2026-05-04): REFERRED TO INSURANCE
What is NY A 11256 about?
Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.
Who sponsors NY A 11256?
Josh Jensen is the primary sponsor of NY A 11256.
Description
Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.
- Introduced
- —
- Latest action
- 2026-05-04 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- Josh Jensenprimary
Committees
Not provided by source.
Action timeline
2026-05-04
REFERRED TO INSURANCE
referral-committee
Versions
- A11256Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 11256. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.